Saleh H A, Aburashed A, Bober P, Tabaczka P
Department of Pathology, Section of Gastroenterology Grace Hospital, Detroit, Michigan 48235, USA.
Am J Gastroenterol. 1998 Jun;93(6):980-4. doi: 10.1111/j.1572-0241.1998.00292.x.
P53 protein immunohistochemical (IHC) expression was investigated in a series of colonic adenomas and carcinomas to determine the p53 immunohistochemical expression of adenomas in general compared with carcinomas, the difference in staining pattern between adenomas with associated carcinoma and those without associated carcinoma, and the difference in p53 staining in the usual adenomas (low-grade dysplasia) compared with those harboring high-grade dysplasia.
The study involved a series of 20 adenomas without concurrent carcinoma (group 1 adenoma), 29 adenomas with concurrent carcinoma (group 2 adenoma), and 20 carcinomas. Sections of the paraffin-embedded tissues were stained with DO-7 p53 monoclonal antibody after microwave antigen-retrieval method. Cases with nuclear staining in > or = 20% of the tumor cells were considered positive.
Analysis of results showed that 65% of carcinomas and 37% of all adenomas were reactive with p53 IHC staining (p = 0.03). With respect to the adenomas, 30% of group 1 and 41% of group 2 adenomas were reactive for p53 protein (p = 0.42).
Our data demonstrate a statistically significant higher p53 expression rate in colonic carcinomas than in adenomas, and that adenomas with concurrent carcinomas are more frequently p53 positive than those without concurrent carcinoma, but this was not statistically significant. Also, p53 expression is more frequent and intense in adenomas with high-grade dysplasia (10/20, 50%) than in ordinary adenomas with low-grade dysplasia (8/29, 28%), which suggests a strong correlation between the degree of dysplasia in colonic neoplasia and p53 expression pattern.
研究一系列结肠腺瘤和癌组织中p53蛋白免疫组化(IHC)表达情况,以确定腺瘤与癌相比总体的p53免疫组化表达、伴有癌的腺瘤与不伴有癌的腺瘤之间染色模式的差异,以及普通腺瘤(低级别发育异常)与高级别发育异常腺瘤之间p53染色的差异。
该研究纳入了20例无同期癌的腺瘤(第1组腺瘤)、29例伴有同期癌的腺瘤(第2组腺瘤)以及20例癌组织。石蜡包埋组织切片经微波抗原修复法后用DO-7 p53单克隆抗体染色。肿瘤细胞中核染色≥20%的病例被视为阳性。
结果分析显示,65%的癌组织和37%的所有腺瘤对p53免疫组化染色呈反应性(p = 0.03)。就腺瘤而言,第1组腺瘤的30%和第2组腺瘤的41%对p53蛋白呈反应性(p = 0.42)。
我们的数据表明,结肠癌中p53表达率在统计学上显著高于腺瘤,且伴有癌的腺瘤比不伴有癌的腺瘤更频繁地呈p53阳性,但这在统计学上无显著差异。此外,高级别发育异常的腺瘤(10/20,50%)中p53表达比低级别发育异常的普通腺瘤(8/29,28%)更频繁且更强烈,这表明结肠肿瘤发育异常程度与p53表达模式之间存在密切关联。